China SXT Pharmaceuticals annual total assets
2018
2019
2020
2021
2022
2023
2024
2025
2026
China SXT Pharmaceuticals Total Assets Growth & History (SXTC)
China SXT Pharmaceuticals's total assets was $34.8M for fiscal 2026.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $34.8M | $13.1M | +60.43% |
| 2025 | 2025-03-31 | $21.7M | −$1.5M | −6.33% |
| 2024 | 2024-03-31 | $23.1M | −$6.4M | −21.75% |
| 2023 | 2023-03-31 | $29.6M | −$4.0M | −11.90% |
| 2022 | 2022-03-31 | $33.5M | −$1.0M | −2.90% |
| 2021 | 2021-03-31 | $34.5M | $12.8M | +59.19% |
| 2020 | 2020-03-31 | $21.7M | $4.2M | +24.22% |
| 2019 | 2019-03-31 | $17.5M | $9.8M | +128.14% |
| 2018 | 2018-03-31 | $7.7M | — | — |
China SXT Pharmaceuticals quarterly total assets
Q4.18
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | $34.8M | $13.1M | +60.43% |
| Q2 2026 | 2025-09-30 | $26.4M | −$4.6M | −14.98% |
| Q4 2025 | 2025-03-31 | $21.7M | −$1.5M | −6.33% |
| Q2 2025 | 2024-09-30 | $31.0M | $16.4M | +112.49% |
| Q4 2024 | 2024-03-31 | $23.1M | −$6.4M | −21.75% |
| Q2 2024 | 2023-09-30 | $14.6M | −$7.6M | −34.23% |
| Q4 2023 | 2023-03-31 | $29.6M | −$4.0M | −11.90% |
| Q2 2023 | 2022-09-30 | $22.2M | −$489,102 | −2.16% |
| Q4 2022 | 2022-03-31 | $33.5M | −$1.0M | −2.90% |
| Q2 2022 | 2021-09-30 | $22.7M | −$1.4M | −5.71% |
| Q4 2021 | 2021-03-31 | $34.5M | $12.8M | +59.19% |
| Q2 2021 | 2020-09-30 | $24.0M | $996,928 | +4.33% |
| Q4 2020 | 2020-03-31 | $21.7M | $4.2M | +24.22% |
| Q2 2020 | 2019-09-30 | $23.0M | — | — |
| Q4 2019 | 2019-03-31 | $17.5M | $9.8M | +128.14% |
| Q4 2018 | 2018-03-31 | $7.7M | — | — |
China SXT Pharmaceuticals total assets trends
Over the last five fiscal years, China SXT Pharmaceuticals's total assets increased from $34.5M to $34.8M, a change of $206,972. The latest reported quarter, Q4 2026, shows $34.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China SXT Pharmaceuticals source filings ↗